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Last week more than 400 public health doctors, specialists, and
academics from across the country wrote an open letter to the
House of Lords stating that the Health and Social Care Bill will
do “irreparable harm to the NHS, to individual patients, and to
society as a whole,” that it will “erode the NHS’s ethical and
cooperative foundations,” and that it will “not deliver efficiency,
quality, fairness, or choice.”1
The prime minister claimed that the letter actually supported
aspects of the bill, while the secretary of state for health was
dismissive, maintaining that people signed it without reading it
and that it was “politically motivated” and unsupported by “a
shred of evidence.”
These claims were wrong. There was no qualified support for
the bill. Nor did signatories write in a political capacity: they
wrote in their professional capacity and with the public interest
in mind. Nor are public health professionals alone in having
concerns: the public, the BMA, and many of the royal colleges
continue to express deep and continuing concerns.
Public health professionals are responsible for assessing the
healthcare needs of the entire population. This entails looking
across the entire health system to ensure that its different
components come together efficiently, effectively, and fairly.
They are expected to speak out as advocates for the population
and especially for those people with poorer health outcomes.
But more importantly, our concerns are based on a wealth of
evidence, much published in peer reviewed journals.2-5
There are many problems with the bill. For one, it abolishes
direct accountability of the secretary of state for health to secure
comprehensive care for the whole population and the
mechanisms and structures for securing that duty.6 The health
secretary has also stated that equitable resource allocation will
no longer be his direct responsibility and that national resource
allocation formulas will change from area based populations to
GP registrations, a move that portends a shift towards a model
of competing insurance pools or funds, for which the evidence
from other countries is adverse.7 8
The bill will usher in a new era of commercialisation but still
does not make clear the public duties of the economic regulator,
Monitor. And while the proposed duties of clinical
commissioning groups remain weak, they will be given the
freedom to compete for or select their registered populations,
as well as “flexibilities” in defining which services to provide.
Allowing clinical commissioning groups to also enter into joint
ventures with private companies will create inequalities in
entitlement to care and introduce commercial conflicts of
interest.9
New commercial actors will be driven to compete andmaximise
income, overshadowing the need to cooperate and collaborate
in ways that place the patient and population at the heart of the
health system. The absence of clear responsibilities for
geographically defined populations will make it difficult, if not
impossible, to link clinical NHS commissioning with social care
services or with plans and interventions to act on the social
determinants of health.
While we value clinical engagement in population based
planning and commissioning, the more important problem is
that the bill hands over greater control over public budgets to
the dictates of the market. We believe that most healthcare
professions reject this proposed transformation and are aware
of the clinical, professional, and ethical shortcomings of market
based health systems such as those that exist in the United
States.10
The health secretary has called for a debate that is based on
evidence. We agree. But this requires transparency about the
evidence base and the intentions that have shaped the bill. So
far, the proposed structures do not conform to the goal of a
universal and equitable health service, free at the point of
delivery, and accessed on the basis of need and not ability to
pay.
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